Eli Lilly Archives - Express Pharma

Obesity care needs greater revolution: GlobalData

GLP-1R agonist withdrawal effect on weight loss and cardiovascular risks remains unmet need: GlobalData

FDA rejection to delay Lebrikizumab chances to enter atopic dermatitis market: GlobalData

Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData

Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis

Eli Lilly to invest $450 million more to expand capacity as obesity drug decision looms

AbbVie and Eli Lilly exit UK drug pricing agreement

Eli Lilly introduces Ramiven (abemaciclib) in India

Lilly’s Taltz now available in new, citrate-free formulation to reduce injection site pain

US FDA approves Lilly and Incyte’s Olumiant for treating certain hospitalised patients with COVID-19